Inside the $10 Optical Spectrometer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Inside the $10 Optical Spectrometer

  • October 27, 2026

  • 3 min

Share

Objective:

To develop and evaluate a compact, low-cost near-infrared spectrometer for identifying materials and measuring concentrations, and to explore its potential for noninvasive biomarker monitoring.

Approach:
  • Device: ConvSpec uses the convolution theorem to convert optical signals into spectra. The packaged instrument measured 4.8 × 6.2 × 0.6 cm, weighed 16.5 g, cost an estimated $10 in components, and covered wavelengths of about 1,200–1,700 nm.
  • Laboratory evaluation: Researchers tested spectral resolution, temperature correction, classification of several materials, and concentration measurements for ethanol, lactate, glucose, and ethylene glycol.
  • Human evaluation: A wrist-worn probe collected about 6,000 spectra across 126 participant sessions. Measurements were compared with reference values from established methods.
Key Findings:
  • The device collected and processed each spectrum in less than 0.4 seconds and distinguished peaks separated by 5.8 cm−1.
  • Machine-learning models correctly classified all samples in the internal test sets for plastics, pharmaceuticals, coffee, flour, and tea.
  • For solution concentration measurements, mean absolute errors ranged from 0.006 to 0.017 percent; glucose predictions were more accurate than those from the tested commercial benchtop spectrometers.
  • In exploratory human testing, reported mean absolute errors were 2.49% for skin moisture, 1.70 mg/dL for blood alcohol, 0.81 mmol/L for lactate, and 0.36 mmol/L for glucose.
  • Glucose models did not reliably predict levels in new participants, with individual physiological differences affecting measured spectra.
Interpretation:

The study demonstrated a small, low-cost instrument for laboratory material and concentration measurements and explored wrist-based biomarker measurement. It did not establish ConvSpec as a clinical diagnostic test.

Limitations:
  • Human testing was exploratory, conducted under controlled conditions, and involved Asian adults.
  • Glucose predictions did not reliably generalize to new participants.
Conclusion:

ConvSpec demonstrated laboratory material classification and concentration measurement, and was also evaluated in exploratory wrist-based biomarker measurements. The study did not establish clinical diagnostic performance; glucose predictions did not reliably generalize to new participants.

Sources:

Original Source(s)

Related Content